Safety evaluation and comparative analysis of rituximab and adalimumab based on openFDA
REN Yuqin, LI Xin, YU Min, SU Yuwen
Chinese Journal of Pharmacovigilance . 2022, (7): 752 -756 .  DOI: 10.19803/j.1672-8629.2022.07.12